Relationship of Ambulatory Blood Pressure and the Heart Rate Profile with Renal Function Parameters in Hypertensive Patients with Chronic Kidney Disease

REFERENCES

• Dahlof B, Devereux RB, Kjeldsen SE, . Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359:995–1003.
   PubMed Web of Science ®Google Scholar
• Casas JP, Chua W, Loukogeorgakis S, . Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. Lancet 2005; 366:2026–2033.
   PubMed Web of Science ®Google Scholar
• Spallone V, Bernardi L, Ricordi L, . Relationship between the circadian rhythms of blood pressure and sympathovagal balance in diabetic autonomic neuropathy. Diabetes 1993; 42:1745–1752.
   PubMed Web of Science ®Google Scholar
• Nakano S, Fukuda M, Hotta F, . Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects. Diabetes 1998; 47:1501–1506.
   PubMed Web of Science ®Google Scholar
• Sturrock ND, George E, Pound N, Stevenson J, Peck GM, Sowter H. Non-dipping circadian blood pressure and renal impairment are associated with increased mortality in diabetes mellitus. Diabetes Med 2000; 17:360–364.
   PubMed Web of Science ®Google Scholar
• Palmas W, Pickering TG, Teresi J, . Ambulatory blood pressure monitoring and all-cause mortality in elderly people with diabetes mellitus. Hypertension 2009; 53:120–127.
   PubMed Web of Science ®Google Scholar
• Williams B, Lacy PS, Thom SM, . Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113:1213–1225.
   PubMed Web of Science ®Google Scholar
• Wang KL, Cheng HM, Chuang SY, . Central or peripheral systolic or pulse pressure: which best relates to target organs and future mortality? J Hypertens 2009; 27:461–467.
   PubMed Web of Science ®Google Scholar
• Wang KL, Cheng HM, Sung SH, . Wave reflection and arterial stiffness in the prediction of 15-year all-cause and cardiovascular mortalities: a community-based study. Hypertension 2010; 55:799–805.
   PubMed Web of Science ®Google Scholar
• Gomez-Marcos MA, Recio-Rodriguez JI, Rodriguez-Sanchez E, . Central blood pressure and pulse wave velocity: relationship to target organ damage and cardiovascular morbidity–mortality in diabetic patients or metabolic syndrome. An observational prospective study. LOD-DIABETES study protocol. BMC Public Health 2010; 10:143.
   PubMed Web of Science ®Google Scholar
• Vlachopoulos C, Aznaouridis K, O’Rourke MF, Safar ME, Baou K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J 2010; 31:1865–1871.
   PubMed Web of Science ®Google Scholar
• Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010; 55:1318–1327.
   PubMed Web of Science ®Google Scholar
• Huang CM, Wang KL, Cheng HM, . Central versus ambulatory blood pressure in the prediction of all-cause and cardiovascular mortalities. J Hypertens 2011; 29:454–459.
   PubMed Web of Science ®Google Scholar
• Tamura K, Tsurumi Y, Sakai M, . A possible relationship of nocturnal blood pressure variability with coronary artery disease in diabetic nephropathy. Clin Exp Hypertens 2007; 29:31–42.
   PubMed Web of Science ®Google Scholar
• Ozawa M, Tamura K, Okano Y, . Identification of an increased short-term blood pressure variability on ambulatory blood pressure monitoring as a coronary risk factor in diabetic hypertensives. Clin Exp Hypertens 2009; 31:259–270.
   PubMed Web of Science ®Google Scholar
• Kanaoka T, Tamura K, Moriya T, . Effects of multiple factorial intervention on ambulatory BP profile and renal function in hypertensive type 2 diabetic patients with overt nephropathy – a pilot study. Clin Exp Hypertens 2011; 33:255–263.
   PubMed Web of Science ®Google Scholar
• Tamura K, Yamauchi J, Tsurumi-Ikeya Y, . Ambulatory blood pressure and heart rate in hypertensives with renal failure: comparison between diabetic nephropathy and non-diabetic glomerulopathy. Clin Exp Hypertens 2008; 30:33–43.
   PubMed Web of Science ®Google Scholar
• Kikuya M, Hozawa A, Ohokubo T, . Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension 2000; 36:901–906.
   PubMed Web of Science ®Google Scholar
• Sander D, Kukla C, Klingelhofer J, Winbeck K, Conrad B. Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: a 3-year follow-up study. Circulation 2000; 102:1536–1541.
   PubMed Web of Science ®Google Scholar
• Eto M, Toba K, Akishita M, . Impact of blood pressure variability on cardiovascular events in elderly patients with hypertension. Hypertens Res 2005; 28:1–7.
   PubMed Web of Science ®Google Scholar
• Mitsuhashi H, Tamura K, Yamauchi J, . Effect of losartan on ambulatory short-term blood pressure variability and cardiovascular remodeling in hypertensive patients on hemodialysis. Atherosclerosis 2009; 207:186–190.
   PubMed Web of Science ®Google Scholar
• Masuda S, Tamura K, Wakui H, . Effects of angiotensin II type 1 receptor blocker on ambulatory blood pressure variability in hypertensive patients with overt diabetic nephropathy. Hypertens Res 2009; 32:950–955.
   PubMed Web of Science ®Google Scholar
• Ozawa M, Tamura K, Okano Y, . Blood pressure variability as well as blood pressure level is important for left ventricular hypertrophy and brachial-ankle pulse wave velocity in hypertensives. Clin Exp Hypertens 2009; 31:669–679.
   PubMed Web of Science ®Google Scholar
• Matsuo S, Imai E, Horio M, . Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53:982–992.
   PubMed Web of Science ®Google Scholar
• Takazawa K, Kobayashi H, Shindo N, Tanaka N, Yamashina A. Relationship between radial and central arterial pulse wave and evaluation of central aortic pressure using the radial arterial pulse wave. Hypertens Res 2007; 30:219–228.
   PubMed Web of Science ®Google Scholar
• Kips JG, Schutte AE, Vermeersch SJ, . Comparison of central pressure estimates obtained from SphygmoCor, Omron HEM-9000AI and carotid applanation tonometry. J Hypertens 2011; 29:1115–1120.
   PubMed Web of Science ®Google Scholar
• Rezai MR, Goudot G, Winters C, Finn JD, Wu FC, Cruickshank JK. Calibration mode influences central blood pressure differences between SphygmoCor and two newer devices, the Arteriograph and Omron HEM-9000. Hypertens Res 2011; 34:1046–1051.
   PubMed Web of Science ®Google Scholar
• Tomiyama H, Odaira M, Matsumoto C, . Effects of moderate-to-severe impairment of the estimated glomerular filtration rate and of proteinuria on the central hemodynamics and arterial stiffness in middle-aged healthy Japanese men. Int J Nephrol 2011; 2011:427–471.
   Google Scholar
• Yamashina A, Tomiyama H, Takeda K, . Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002; 25:359–364.
   PubMed Web of Science ®Google Scholar
• Takebayashi K, Matsutomo R, Matsumoto S, . Relationships between heart rate variability and urinary albumin excretion in patients with type 2 diabetes. Am J Med Sci 2006; 331:72–78.
   PubMed Web of Science ®Google Scholar
• Boulatov VA, Stenehjem A, Os I. Association between albumin:creatinine ratio and 24-hour ambulatory blood pressure in essential hypertension. Am J Hypertens 2001; 14:338–344.
   PubMed Web of Science ®Google Scholar
• Palmas W, Moran A, Pickering T, . Ambulatory pulse pressure and progression of urinary albumin excretion in older patients with type 2 diabetes mellitus. Hypertension 2006; 48:301–308.
   PubMed Web of Science ®Google Scholar
• Marcovecchio ML, Dalton RN, Schwarze CP, . Ambulatory blood pressure measurements are related to albumin excretion and are predictive for risk of microalbuminuria in young people with type 1 diabetes. Diabetologia 2009; 52:1173–1181.
   PubMed Web of Science ®Google Scholar
• Nishimura M, Uzu T, Fujii T, Kimura G. Disturbed circadian rhythm of urinary albumin excretion in non-dipper type of essential hypertension. Am J Nephrol 2002; 22:455–462.
   PubMed Web of Science ®Google Scholar
• Palmas W, Pickering T, Teresi J, . Nocturnal blood pressure elevation predicts progression of albuminuria in elderly people with type 2 diabetes. J Clin Hypertens (Greenwich) 2008; 10:12–20.
   PubMed Web of Science ®Google Scholar
• Jamerson K, Weber MA, Bakris GL, . Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008; 359:2417–2428.
   PubMed Web of Science ®Google Scholar
• Matsushita K, van der Velde M, Astor BC, . Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375:2073–2081.
   PubMed Web of Science ®Google Scholar
• Bakris GL, Sarafidis PA, Weir MR, . Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial. Lancet 2010; 375:1173–1181.
   PubMed Web of Science ®Google Scholar
• Fukuta H, Hayano J, Ishihara S, . Prognostic value of heart rate variability in patients with end-stage renal disease on chronic haemodialysis. Nephrol Dial Transplant 2003; 18:318–325.
   PubMed Web of Science ®Google Scholar
• Oikawa K, Ishihara R, Maeda T, . Prognostic value of heart rate variability in patients with renal failure on hemodialysis. Int J Cardiol 2009; 131:370–377.
   PubMed Web of Science ®Google Scholar
• Pop-Busui R, Evans GW, Gerstein HC, . Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care 2010; 33:1578–1584.
   PubMed Web of Science ®Google Scholar
• Chandra P, Sands RL, Gillespie BW, . Predictors of heart rate variability and its prognostic significance in chronic kidney disease. Nephrol Dial Transplant 2012; 27:700–709.
   PubMed Web of Science ®Google Scholar
• Hou FF, Ren H, Owen WF Jr, . Enhanced expression of receptor for advanced glycation end products in chronic kidney disease. J Am Soc Nephrol 2004; 15:1889–1896.
   PubMed Web of Science ®Google Scholar
• Candido R, Forbes JM, Thomas MC, . A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes. Circ Res 2003; 92:785–792.
   PubMed Web of Science ®Google Scholar
• Jandeleit-Dahm K, Lassila M, Allen T. Advanced glycation end products in diabetes-associated atherosclerosis and renal disease: interventional studies. Ann N Y Acad Sci 2005; 1043:759–766.
   PubMed Web of Science ®Google Scholar
• Miyata T, Ueda Y, Horie K, . Renal catabolism of advanced glycation end products: the fate of pentosidine. Kidney Int 1998; 53:416–422.
   PubMed Web of Science ®Google Scholar
• Piroddi M, Palazzetti I, Quintaliani G, . Circulating levels and dietary intake of the advanced glycation end-product marker carboxymethyl lysine in chronic kidney disease patients on conservative predialysis therapy: a pilot study. J Ren Nutr 2011; 21:329–339.
   PubMed Web of Science ®Google Scholar
• Ohishi M, Tatara Y, Ito N, . The combination of chronic kidney disease and increased arterial stiffness is a predictor for stroke and cardiovascular disease in hypertensive patients. Hypertens Res 2011; 34:1209–1215.
   PubMed Web of Science ®Google Scholar
• Moriya T, Tanaka K, Hosaka T, Hirasawa Y, Fujita Y. Renal structure as an indicator for development of albuminuria in normo- and microalbuminuric type 2 diabetic patients. Diabetes Res Clin Pract 2008; 82:298–304.
   PubMed Web of Science ®Google Scholar
• Ohnuki K, Umezono T, Abe M, . Expression of transcription factor Snai1 and tubulointerstitial fibrosis in progressive nephropathy. J Nephrol 2012; 25:233–239.
   PubMed Web of Science ®Google Scholar